2003
DOI: 10.1172/jci16116
|View full text |Cite
|
Sign up to set email alerts
|

Inhibition of skin tumor growth and angiogenesis in vivo by activation of cannabinoid receptors

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

16
235
0

Year Published

2006
2006
2022
2022

Publication Types

Select...
10

Relationship

1
9

Authors

Journals

citations
Cited by 208 publications
(251 citation statements)
references
References 34 publications
16
235
0
Order By: Relevance
“…Although this very surprising aspect of cannabinoid action has been already documented in other sets of experiments [39][40][41][42], there is not at the moment a convincing explanation for this behavior. It may be that this dual property depends on differences in the features of normal versus transformed cells.…”
Section: Discussionmentioning
confidence: 77%
“…Although this very surprising aspect of cannabinoid action has been already documented in other sets of experiments [39][40][41][42], there is not at the moment a convincing explanation for this behavior. It may be that this dual property depends on differences in the features of normal versus transformed cells.…”
Section: Discussionmentioning
confidence: 77%
“…CNR2 is the "peripheral" cannabinoid receptor, mostly expressed by cells of the immune system and responsible for mediating the non-psychoactive effects of cannabinoids such as analgesia and immunosuppression [27]. Although relatively little is known about the cannabinoid receptors, CNR2 has evoked medical interest as an inducer of apoptosis, inhibitor of angiogenesis and skin tumour growth [28], and a potent antiinflammatory and immunosuppressive agent. [29].…”
Section: Experimental Validation Of the Microarray Resultsmentioning
confidence: 99%
“…Namely, it was shown that exogenous or endogenous cannabinoid and vanilloid ligands induced in vitro growthinhibition and (apoptotic or necrotic) cell death of the PCC cell lines expressing CB1 and TRPV1 (Nithipatikom et al 2004;Sarfaraz et al 2005;Sanchez et al 2005Sanchez et al , 2006Mori et al 2006). Furthermore, recent reports presented that vanilloids in vivo eVectively prevented the growth or induced the regression of xenograft tumors induced by PCC-derived cell lines (Sanchez et al 2006;Mori et al 2006), similar to the action of cannabinoids on skin tumors (Casanova et al 2003).…”
Section: Introductionmentioning
confidence: 80%